All News #Library
Biotech
Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept
02 Aug 2023 //
GLOBENEWSWIRE
Aravive to Present Updated Clinical Data from Batiraxcept Trials
28 Jul 2023 //
GLOBENEWSWIRE
Aravive to Participate in William Blair`s Innovator Series
14 Jul 2023 //
GLOBENEWSWIRE
Aravive Announces Ph3 Trial Design for Batiraxcept in Renal Cell Carcinoma
16 May 2023 //
GLOBENEWSWIRE
Aravive to Host Virtual KOL Event on its Late-Stage Oncology Asset Batiraxcept
08 May 2023 //
GLOBENEWSWIRE
Aravive to Present Positive Data from P1b Trial of Batiraxcept with Cabozantinib
13 Feb 2023 //
GLOBENEWSWIRE
Aravive Announces Complete Enrollment in PIII AXLerate-OC Trial
04 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support